Brief: AFT Pharmaceuticals Says Welcome US FDA Approval For Sale Of Maxigesic IV
18/10/2023 02:31
Oct 18 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* AFT WELCOMES US FDA APPROVAL FOR SALE OF MAXIGESIC IV
* AFT WELCOMES US FDA APPROVAL FOR SALE OF MAXIGESIC IV
* HAS BEEN NOTIFIED OVERNIGHT THAT U.S. FDA APPROVED
MAXIGESIC IV
FOR SALE IN U.S.
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV